CUSIP: Y95308105
Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
182,917,028
-
Total 13F shares
-
20,492,602
-
Share change
-
+1,176,369
-
Total reported value
-
$445,796,252
-
Price per share
-
$21.75
-
Number of holders
-
58
-
Value change
-
+$26,521,810
-
Number of buys
-
32
-
Number of sells
-
17
Quarterly Holders Quick Answers
What is CUSIP Y95308105?
CUSIP Y95308105 identifies WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2017
-
Previous quarter:
Q2 2017
Recent filing periods for CUSIP Y95308105:
Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q3 2017
As of 30 Sep 2017,
Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,492,602 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Foresite Capital Management III, LLC, New Leaf Venture Partners, L.L.C., PERCEPTIVE ADVISORS LLC, Point72 Asset Management, L.P., BlackRock Inc., and DEERFIELD MANAGEMENT CO.
This page lists
58
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.